The FDA has announced pergolide is to be voluntarily withdrawn for human use. Pergolide is commonly used for horses with pituitary pars intermedia dysfunction (PPID), also known as equine Cushing's disease.
According to the FDA announcement, all pergolide products (Permax and two generic formulas) will be withdrawn for human use. Pergolide has been used as a treatment for Parkinson's
To continue reading this article, become a member of TheHorse.com.
It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.







